DiagnosTechs - Clinical and Research Laboratory Revenue and Competitors

Seattle, WA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • DiagnosTechs - Clinical and Research Laboratory's estimated annual revenue is currently $14.3M per year.(i)
  • DiagnosTechs - Clinical and Research Laboratory's estimated revenue per employee is $243,000

Employee Data

  • DiagnosTechs - Clinical and Research Laboratory has 59 Employees.(i)
  • DiagnosTechs - Clinical and Research Laboratory grew their employee count by 7% last year.

DiagnosTechs - Clinical and Research Laboratory's People

NameTitleEmail/Phone
1
Medical Support Physician and Project ManagerReveal Email/Phone
2
Technical Supervisor/ParasitologistReveal Email/Phone
3
Medical Billing SpecialistReveal Email/Phone
4
Laboratory TechnicianReveal Email/Phone
5
Medical Billing SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8M376%N/AN/A
#2
$8.6M408%N/AN/A
#3
$7.3M3410%N/AN/A
#4
$10.8M5016%N/AN/A
#5
$74.3M2503%N/AN/A
#6
$70.4M2376%N/AN/A
#7
$24.3M90-7%N/AN/A
#8
$44M14812%N/AN/A
#9
$30.8M1146%N/AN/A
#10
$7.8M36-8%N/AN/A
Add Company

What Is DiagnosTechs - Clinical and Research Laboratory?

Founded in 1987, DiagnosTechsâ„¢ is a pioneer and leader in saliva-based testing. Our commitment to assisting healthcare professionals in restoring patients' health and wellness is unsurpassed with over 1.2 million specimens tested per year. Saliva testing is a powerful tool for evaluating stress, hormone-related disease and health conditions, especially over time. DiagnosTechs continually improves and refines its laboratory testing standards, using cutting-edge technology and methods. Many healthcare providers and their patients have chosen DiagnosTechs as their partner in wellness.

keywords:N/A

N/A

Total Funding

59

Number of Employees

$14.3M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.6M60-12%N/A
#2
$13.3M61-6%$18M
#3
$17.9M629%N/A
#4
$5.6M627%N/A
#5
$10.6M6714%N/A